# Open Label Trial of Aripiprazole in Children and Adolescents With Tourette's Disorder

> **NCT00241176** · PHASE4 · COMPLETED · sponsor: **NYU Langone Health** · enrollment: 11 (actual)

## Conditions studied

- Tourette's Syndrome
- Tic Disorders

## Interventions

- **DRUG:** Aripiprazole

## Key facts

- **NCT ID:** NCT00241176
- **Lead sponsor:** NYU Langone Health
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-09
- **Primary completion:** 2008-08
- **Final completion:** 2010-02
- **Target enrollment:** 11 (ACTUAL)
- **Last updated:** 2016-12-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00241176

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00241176, "Open Label Trial of Aripiprazole in Children and Adolescents With Tourette's Disorder". Retrieved via AI Analytics 2026-08-24 from https://api.ai-analytics.org/clinical/NCT00241176. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*